| pubmed-article:7694822 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C0039005 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C1135183 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C0123257 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C0074825 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C0242210 | lld:lifeskim |
| pubmed-article:7694822 | lifeskim:mentions | umls-concept:C1515670 | lld:lifeskim |
| pubmed-article:7694822 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7694822 | pubmed:dateCreated | 1993-12-23 | lld:pubmed |
| pubmed-article:7694822 | pubmed:abstractText | 1. Diabetes had no significant effect on IGFBP-3 message and serum levels however, subsequent insulin treatment caused more than a two-fold increase in both hepatic IGFBP-3 mRNA and serum levels above controls (P < 0.05). 2. The induction of diabetes in pigs significantly increased the steady state levels of IGFBP-2 mRNA in the liver of young swine (P < 0.05). 3. Both liver message and serum IGFBP-2 were reduced to control levels with insulin therapy. 4. We report here that in addition to its affects on IGFBP-2, insulin is involved in the regulation of IGFBP-3 expression. | lld:pubmed |
| pubmed-article:7694822 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7694822 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7694822 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7694822 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7694822 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7694822 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7694822 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7694822 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7694822 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7694822 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7694822 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7694822 | pubmed:issn | 0305-0491 | lld:pubmed |
| pubmed-article:7694822 | pubmed:author | pubmed-author:WhiteM EME | lld:pubmed |
| pubmed-article:7694822 | pubmed:author | pubmed-author:RamsayT GTG | lld:pubmed |
| pubmed-article:7694822 | pubmed:author | pubmed-author:ErnstC WCW | lld:pubmed |
| pubmed-article:7694822 | pubmed:author | pubmed-author:LeamanD WDW | lld:pubmed |
| pubmed-article:7694822 | pubmed:author | pubmed-author:OsborneJ MJM | lld:pubmed |
| pubmed-article:7694822 | pubmed:author | pubmed-author:KampmanK AKA | lld:pubmed |
| pubmed-article:7694822 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7694822 | pubmed:volume | 106 | lld:pubmed |
| pubmed-article:7694822 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7694822 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7694822 | pubmed:pagination | 341-7 | lld:pubmed |
| pubmed-article:7694822 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:meshHeading | pubmed-meshheading:7694822-... | lld:pubmed |
| pubmed-article:7694822 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:7694822 | pubmed:articleTitle | Insulin-like growth-factor binding protein (IGFBP) serum levels and hepatic IGFBP-2 and -3 mRNA expression in diabetic and insulin-treated swine (Sus scrofa). | lld:pubmed |
| pubmed-article:7694822 | pubmed:affiliation | Department of Animal Science, University of Minnesota, St Paul 55108. | lld:pubmed |
| pubmed-article:7694822 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7694822 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
